Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population

By J. Warren, C. Klabunde, D. Schrag, P. Bach, G. Riley. Medical Care, 2002

1,792 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Geriatrics and Gerontology, Oncology

View Paper: https://www.semanticscholar.org/paper/f424867b2d8d7f6f2cdfeb5d8535efe7cc1c8499

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. A. Mariotto
2. A. Jemal
3. S. Greenfield
4. M. Hewitt
5. Jiemin Ma
6. E. Stovall
7. R. Siegel

In Geriatrics and Gerontology

1. S. Greenfield
2. E. Stovall
3. M. Hewitt
4. A. Mariotto

In Oncology

1. A. Jemal
2. A. Mariotto
3. R. Siegel
4. Elizabeth E. Ward
5. Jiemin Ma
6. E. Stovall
7. S. Greenfield
8. M. Hewitt

Citations in the corpus

• Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 (2015, methodology): “This database links cancer registry data from the National Cancer Institute’s SEER program with Medicare enrollment and claims files.(8,9) The data files used included Patient Entitlement and Diagnosis Summary File (PEDSF), inpatient claims known as Medicare Provider Analysis and Review (MEDPAR) fil”
• Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study (2011, background): “The program’s standard for registry completeness for the incidence of cancer cases is 98% [9].”
• Projections of the cost of cancer care in the United States: 2010-2020. (2011, methodology): “Bladder 514 000 629 000 (22) 576 000 (12) 640 000 (14) 587 000 (14) Brain 139 000 176 000 (27) 174 000 (25) 185 000 (31) 182 000 (31) Breast 3 461 000 4 538 000 (31) 4 275 000 (24) 4 597 000 (25) 4 329 000 (25) Cervix 281 000 276 000 (22) 245 000 (213) 277 000 (213) 245 000 (213) Colorectal 1 216 00”
• A population-based study of cardiovascular disease mortality risk in US cancer patients. (2019, methodology): “The SEER program is a network of population-based incident tumour registries, covering 28% of the US population, including incidence, survival, and treatment.(15,16) Cause of death was categorized by the International Classification of Diseases (ICD)-9 code.”
• Annual Report to the Nation on the Status of Cancer, 1975-2010, Featuring Prevalence of Comorbidity and Impact on Survival among Persons with Lung, Colorectal, Breast or Prostate Cancer (2013, methodology): “Comorbidity Among Older Cancer Patients and the Medicare Population The comorbidity analyses included a cohort of cancer patients diagnosed between 1992 and 2005 who resided in 11 SEER areas and whose data have been linked to Medicare claims data and a 5% random sample of cancer-free Medicare benefi”
• From cancer patient to cancer survivor : lost in transition (2006, background): “One of the most fruitful linkages for cancer care assessment is that of the SEER cancer registries to claims records in Medicare’s administrative database (Potosky et al., 1993; Warren et al., 2002).”
• Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival (2017, methodology): “The NCI has created a valuable national resource for such studies by linking SEER registry data to Medicare records to augment data on treatments and comorbidities (97).”
• Anticipating the ‘Silver Tsunami’: Prevalence Trajectories and Co-Morbidity Burden Among Older Cancer Survivors in the United States (2016, methodology): “Procedures for calculating comorbidity burden Claims from the November 2014 SEER-Medicare linkage data and from a 5% random sample of Medicare beneficiaries residing in the SEER areas free of cancer were used to describe comorbidity burden (18).”